Search

everythinglearnresearchcommunity

for

Search:↓

Unani medicine links diffuse hair loss to poor skin pore function and body dryness, leading to thinning hair.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Most types of hair loss can regrow naturally, but there are no effective cures for male pattern or age-related hair loss, and only limited options for females.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Low-level light therapy, possibly combined with other treatments, may become a leading hair loss treatment, while hirsutism often worsens with age and lacks preventive options.

Hair grows in three stages: growing, transition, and resting.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Hypothyroidism patients with hair loss typically have thinning hair, smaller hair follicles, and normal hair shedding.

Stress hormone CRF causes hair loss and inhibits hair growth in human cells.

Stress hormone CRF causes hair loss and stops hair cell growth.

Telogen effluvium is a form of hair loss caused by various factors and requires identifying the cause for proper treatment.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Oral contraceptives may cause hair loss in women.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.

Telogen Effluvium is a condition where more hair than usual falls out after stress or fever.

A woman's temporary hair loss was caused by high prolactin levels from her medication.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Cinchona succirubra extract with caffeine reduces hair loss and strengthens hair.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Hair loss from telogen effluvium may not happen again after another surgery.

Etretinate treatment changed hair growth patterns in many patients.

Sandalore® improves hair growth and quality in people with hair loss.